COSCIENS Biopharma Inc (CSCI)

[livendi]

i dont think they were lying,maybe there was a problem orthey are trying to cover the dlta and other variants of covid,also covid isnt going anywhere,it will be almost like the flu shot,even people that have been vaccinated are getting it,the other catalysts are true also but again they are a yr out,was counting on covid pill to fill the gap till then,was wrong and it will probably test 50 cents,on the other hand when it does bottom out im buying a lot and will hold,just way too many catalysts coming and some for unmet needs,they have enuf cash till 2024 basically and the float is around 120 mill or so,they also have a low burn rate,forget about it going higher in the short term imo,the time will come whenit will push 5 or 10 bucks imo,problem is that time is probably 6 months to a yr away so till then it could get ugly,remember pedi test is for an unmet need and will sell better than adult test,also u know of the other preclincals trials they have going,again like ive always said the key is other uses for macrilen besides a test,again remember the 2 phase 3 in usa,approval of either 1 will be huge because eu and row will follow the fda like they did the adult test,again the problem is these are a yr out as is just about everything,going to take some time,its going be a long 6 months to a yr,God bless all